University of Florida

Books:

Hartzema AG, Tilson HM, Chen A, editors. Pharmacoepidemiology and Therapeutic Risk Management, Harvey Whitney Books, Cincinnati, Ohio, 2007 (forthcoming)

Hartzema AG, Porta MS, and Tilson HM, editors. Pharmacoepidemiology: An Introduction, Harvey Whitney Books, Cincinnati, Ohio, 1988 - Second Edition, 1991; Third Edition, 1999.

Hartzema AG, Mullins, DC, Pharmaceutical Chartbook, The Haworth Press, Binghamton, NY, 1995.

Hartzema AG, Pharmaceutical Services Chartbook, Lewis Publishers, Chelsea, Michigan, 1990.

Selected Articles:

Richardson L, Wang W, Hartzema AG, Wagner S. The Role of Health-related Quality of Life in Early Discontinuation of Chemotherapy for  Breast Cancer. (Accepted: The Breast Journal)

Johnson MR, Hartzema AG, Mills TL, DeLeon JM, Nelson D, Frueh C, Santos A.  Ethnic differences in the reliability and validity of a panic disorder screen. Ethnicity & Health 2007; 12(3): 1-14.

Hartzema AG, Winterstein AG, Johns T, De Leon J, Baily W, McDonald K, Pannell R.  Planning for Pharmacy Health Informaton Technology (pHIT) in Critical Access Hospitals. American Journal of Health System Pharmacy 2007 Feb 1;64(3):315-21.

Hartzema AG. The Beginnings of Pharmacoepidemiology in The Annals. Ann Pharmacother 2006;40:1647-1648.

Hartzema AG, Porta MS, Tilson HH.  Introduction to Pharmacoepidemiology.  Ann Pharmacother 2006;40:1651-1652.

Siega-Riz A-M, Hartzema AG, Turnbull C, Thorp J, McDonald T, Cogswell ME.  The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: A randomized controlled trial. Am J Obstet Gynecol. 2006;194(2):512-9.

Winterstein AG, Hartzema AG, Johns, TE, De Leon JM, McDonald K, Henshaw Z, Pannell R. Medication Safety Infrastructure in Critical Access Hospitals.  Am J Health Syst Pharm. 2006 Mar 1;63(5):442-50

Zineh I, Pebanco GD, Aquilante CL, Gerhard T, Beitelhees AL, Beasley BN, Hartzema AG. Discordance between availability of pharmacogenomic studies and pharmacogenomic-based prescribing information for the top 200 drugs. Ann Pharmacother. 2006; 40(4): 639-44.

Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG. Corrrection for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women. J. Nutr. 2006;136(2):479-83.

Beaver T, Winterstein AG, Ahsan E, Shuster J, Gerhard T, Martin T, Alexander JA, Johnson R, Ejaz A, Hartzema AG.  Effectiveness of Nesiritide on Dialysis or All-Cause Mortality in Patients Undergoing Cardiothoracic Surgery. Clinical Cardiology 2006;29:18-24.

Gerhard T, Zineh I, Winterstein AG, Hartzema AG. Pharmacoeconomic Modeling of Nesiritide versus Dobutamine for Decompensated Heart Failure.  Pharmacotherapy 2006;26(1):34-43.

Richardson L, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, MacKinnon J.   The role of teaching hospitals, insurance status and race/ethnicity in the receipt of regional-stage breast cancer in Florida. AJPH 2006;96(1):160-6

Winterstein AG, Hartzema AG. The development of quality of care indicators for asthma in community pharmacies. J of Research in Social & Administrative Pharmacy 2005; 1: 430-445.

Jasti S, Siega-Riz AM, Coigswell ME, Hartzema AG, Bentley ME. Pillcount adherence to prenatal Multivitamin/Mineral supplement use among low income women. J Nutr. 2005; 135(5):1093-101.

Zineh I, Gerhard T, Aquilante CL, Beitelhees AL, Beasley BN, Hartzema AG. Availability of Pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs. The Pharmacogenomics Journal 2004:4(6):354-8.

Hartzema AG. Intranasal vaccine for prevention of influenza in children. Am J Health-Syst Pharm 2004; 61: 1716-1720.

Kwon S-Y, Hartzema AG, Duncan P, Lai S-M. Disability measures in Stroke: Relatuionship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke. 2004; 35: 918-23.

Hendeles L, Hartzema AG. Lev albuterol is not more cost-effective than Albuterol for COPD. Letter to the editor. Chest. 2003; 124: 1176.

Shih, Y-CT, Hartzema AG, Tolleson-Rinehart S. Labor costs of incontinence care in long-term care. Urology. 2003; 62: 442-446.

Kettis Lindblad A, Hartzema AG, Jansson L, Feltelius N. Patients’ views of priority setting for new medications: a qualitative study of patients with rheumatoid arthritis. Scandanavian Journal of Rheumatology 2002; 31: 324-9.

Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Attitudinal factors among adult prescription pecipients associated with choice of where to be vaccinated. Journal of Clinical Epidemiology 2002; 55: 279-284.

Pradel F, Bush PJ, Hartzema AG. Children with asthma use of inhalation devices: thechniques, autonomy and perception of ease of use. Journal for Social and Administrative Pharmacy 2001; 18; 178-184.

Grabenstein JD, Gues HA, Hartzema AG, Koch GG, Konrad TR. 1 Effect of vaccination by community pharmacists among adult prescription recipients. Medical Care 2001; 39: 340-8.

 Pradel FG, Hartzema AG, Bush PJ. Asthma selfmanagement: The perspective of childern. Patient Education and Counseling. 2001; 45/3:211-24: 1-14.

Grabenstein JD, Guess HA, Hartzema AG. People vaccinated by community pharmacists: Descriptive Epidemiology. J Am Pharm Assoc 2001; 41:46-52.

Hartzema AG, Day RS, Tolleson-Rinehart S, Sleath B, Bush PJ. Optimizing patient comprehension through medicine information leaflets. Final Report. United States Pharmacopeia, 1999.

Huang X, Hartzema AG, Kauf TL, Norwood GJ, Raasch RH. The economic evaluation of antimicrobial therapy for uncomplicated urinary tract infection in women. Clinical Therapeutics. 1999; 21:1578-1588.

Pradel FG, Hartzema AG, Mutran E, Hanson-Divers C. Physician’s over the counter drug prescribing patterns; An analysis of the National Ambulatory Medical Care Survey. Annals of Pharmacotherapy 1999; 33:400-5.

Almarsdottir AB, Hartzema AG, Bush PJ, Simpson KN, Zimmer C. Childrens’ attitudes and beliefs aout illness and medicines. A triangulation of open-ended and semi-structured interviews. J Social Admin Pharmacy 1997; 14:26-41.

West SL, Savitz SL, Koch G, Sheff KL, Thom BL, Guess HA, Hartzema AG. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. Journal of Clinical Epidimiology. 1997; 50(8):975-80.

Hartzema AG . Foreward to Standards for Economic Evaluation of Drugs. Medical Care, 1996; 125:1-2.

Sirpa W, Kirsti V, Korhonen M, Hartzema AG, Euland H. Self-initiated modification of hypertension treatment in response to perceived problems. Annals of Pharmacotherapy 1995; 29:1213-7.

West SL, Savitz DA, Koch G, Strom BL, Guess H, Hartzema AG. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995; 142:1103-12.

Hanson EC, Hartzema AG. Evaluating pictograms as an aid for counseling elderly and low-literate patients.Journal of Pharmaceutical Marketing and Management 1995; 9(3):41-54

Hartzema AG . Implications for health policy: Chapter in Viewpoints Section. J.P. Bush, Editor, Children, Medicines and Culture, The Haworth Press, Binghamton, N.Y., 1995.

Hartzema AG . Teaching therapeutic reasoning through the case-study approach: Adding the probabilistic dimension. American Journal of Pharmaceutical Education. 1994; 58:436-440.

Hartzema AG . The patient consultation mandate: unresolved issues and viewpoints. Implications for management education and experimental training. American Journal of Pharmacy Education 1993; 57:433-436.

McLeod DC , Cohn, WG, Thayer CF, Perfetto EM, Hartzema, AG. Pharmacoepidemiology of Bleeding Events After Use of 4-Alteplase or Streptokinase in Acute Myocardial Infarction. DICP The Annals of Pharmacotherapy. 1993; 27:956-62.

Boyd AF, Hartzema, AG. Computerized monitoring protocols as a pharmaceutical care practice enhancement: a conceptual illustration using diabetes mellitus, DICP The Annals of Pharmacotherapy. 1993; 27:963-6.

Grabenstein JD, Hartzema AG, Guess HA, Johnston WP. Community Pharmacists as Immunisation Advocates: a pharmacoepidemiologic experiment. International Journal of Pharmacy Practice. 1993; 2:5-10.

Sloane PD, Baldwin R, Montgomery R, Hargett F, Hartzema AG. Left-Sided Leg Edema of the Elderly: A Common Variant of the Iliac Compression Syndrome. Journal American Boards of Family Practice 1993; 6:1-4.

Grabenstein JP, Hartzema AG, Guess HA, Johnston WP, Rittenhouse BE. Community Pharmacists as Immunization Advocates: Cost-Effectiveness of a Cue to Influenza Vaccination. Medical Care, 1992; 30: 503-513.

Hartzema AG . Commentary: Pharmacoepidemiology. Its relevance to clinical practice. Journal of Clinical Pharmacy and Therapeutics, 1992; 17:73-74.

Grabenstein JD, Schroeder, DC, Bjornson DC, Hartzema AG. Pharmacoepidemiology and Military Medical Automation: Opportunity for Excellence. Military Medicine, 1992. 157; 6: 302-307.

Hartzema AG , Perfetto EM, Baldwin R, Johnson C. Strengthening the drug management cycle in a sample of North Carolina Resthomes. Final report to the John A. Hartford Foundation Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, December 1992.

Hartzema AG . Quality of Life Assessments in Clinical Trials, Editor B. Spilker. Book Review. International Pharmacy Journal 1992; 6:19.

Hartzema AG . Guidelines for Evaluating the Pharmacoepidemiologic Literature. The Annals of Pharmacotherapy 1992; 26: 96-98.

Hartzema AG . Improving the Quality of Pharmaceutical Care in Board and Care Facilities. Clinical Outcomes 1991; 2:10-12.

Hartzema AG , Perfetto EM. Internal Rate of Return and Pharmaceutical Sciences Manpower Supply. Pharmaceutical Research, 1991; 8:676-682.

Porta MS, Hartzema AG. The Contribution of Epidemiology to the Study of Drugs. (Translated in Japanese and distributed by the Japanese Pharmaceutical Manufacturers Association to membership firms.)

Hartzema AG , Baldwin R, Perfetto EM, Johnson C. Reducing medication administration errors in family care homes through a program of on-site education and technical assistance. Final report to the Kate B. Reynolds Health Care Trust. Center of Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, May 1991.

Hartzema AG . Control and Validity in Research Design. In: Nnadi-Okolo E., ed. Health Research and Methodology. Boca Raton, FL: CRC Press;1990.

Hartzema AG , Temple D, Wertheimer AI. The organization of continuing education, Part II. Results of an international survey, Pharmacy International, 1990; 4:96-101.

Hartzema AG , Temple D, Wertheimer, AI. The organization of continuing education, Part I. An international literature review, Pharmacy International 1990: 4:56-59.

Hartzema AG , Godbout N, Lee SD, Konrad TR. Measuring Health Locus of Control Among Caregivers in Charge of Medication Administration in Long Term Care Settings. Journal of Social and Administrative Pharmacy, 7(2):84-92, 1990.

Hartzema AG , Konrad TR. Prevention of drug problems in domiciliary care facilities, (Position Paper), The Nation's Health, 17, 21-22, 1987.

Hartzema AG , Organization of Health Care Delivery: Social Forces, Wertheimer AI, Smith MC ed., A Casebook in Social and Behavioral Pharmacy, Harvey Whitney Books, Cincinnati, Ohio, 1987.

Hartzema AG . Capitation reimbursement for pharmacy services, Proceedings from the Sixth International Conference on Pharmacy Economics, PPSI, 1986.

Gagnon JP, Hartzema AG, Mackowiak JI, Diamond WD. Identifying class problems in Schools of Pharmacy, American Journal of Pharmaceutical Education, 49, 246-250 (1985).

Hartzema AG . Report on the competencies in social and behavioral sciences. Submitted to the Pharmacy Administration Section of the American Association of Colleges of Pharmacy, Summer 1985.

Hartzema AG and Thomas III J. The basics of bar code technology in inventory control. Current Concepts in Retail Pharmacy Management, 3, 7-13 (1985).

Hartzema AG . Psycho-social factors in self-medication. In: LE Fryklof and R. Westerling, eds. Self-Medication. Swedish Pharmaceutical Press, Stockholm, 1984.

Hartzema AG and Wertheimer AI. Comparison of three populations on their "expectancies" from self-medication vs. medical care. Journal of Social and Administrative Pharmacy, 1, 80-86 (1983).

Hartzema AG , Christensen DB, and Logerfo J. Non-medical factors associated with the prescribing volume among family practitioners in an HMO. Medical Care, 21, 990-1000 (1983).

Hartzema AG , Pancorbo S, and Davis S. Personality traits and theophylline metabolism. Biopharmaceutics and Drug Disposition, 3, 311-316 (1982).

Hartzema AG . Software for Apple II and Haynes Micro-communication software for Apple II and Haynes micro-modem with UNC and TUC Computer Centers. October, 1982.

Hartzema AG . History of pharmaceutical sciences. Teaching the History and Sociology of Pharmaceutical Sciences, 7, 4, September, 1982.

Hartzema AG . Self-medication: In the scheme of things. Pharmacy Internationale, 3, 57-59 (1982).

Hartzema AG . Drugs and the aged, by WD Poe and DA Holloway. In: Journal of the American Geriatrics Society, 30, 156 (1982).

Hartzema AG , Wertheimer AI, and Rudelius W. Discriminating high and low prescribers. Journal of Health Care Marketing, 1, 8-17 (1981).

Hartzema AG . Pharmacy Practice: social behavioral aspects, 2nd ed., edited by AI Wertheimer and MC Smith. In: Pharmacy Internationale, 3, XI (1981).

Christensen DB, Campbell WH, Madsen S, Hartzema AG, and Nudelman PM. Documenting outpatient problem intervention strategies in an HMO. Medical Care, 19, 104-117 (1981).

Hartzema AG . Domme patient of domme apotheker. Folia Pharmaceutica, 63, 240-243 (1976).

Hartzema AG . Het fenomeen goodwill. Folia Pharmaceutica , 63, 186-188 (1976).

1 Pharmacy Practice Research Award December 2002, American Society for Health-system Pharmacists, J. Grabenstein, H. Guess, AG Hartzema

.